Can a simple infusion stop Immunotherapy's worst side effects?
Disease control
Recruiting now
This study tests whether giving siltuximab alongside restarting immunotherapy can prevent severe immune-related side effects in 40 adults with advanced cancer who previously had such reactions. Participants will receive siltuximab infusions to calm the immune system while resumin…
Phase: PHASE2 • Sponsor: Yuanquan Yang • Aim: Disease control
Last updated May 14, 2026 12:06 UTC